http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-335222-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9ce77af986e4824cb05a336d649405d4
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-397
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-397
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
filingDate 2006-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97effe277fc53aada8c8f614a7baeaf1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2be959293317a264e131ee5973a86962
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1767c5be2f2127d6c48f5c2b2ea7a6f5
publicationDate 2014-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NO-335222-B1
titleOfInvention Means for lowering cholesterol for the prevention or treatment of atherosclerosis as well as single packaging kits comprising such agent.
abstract A serum cholesterol lowering agent or an atherosclerosis prophylactic or therapeutic agent, each comprising a combination of a compound represented by the following general formula (I) or a pharmaceutically acceptable salt thereof with a cholesterol biosynthesis inhibitor and / or a fibrate type cholesterol lowering agent, (l) (b) (a) [1 in the formula, A by formula (a); A 2 is C 1-5 alkyl etc; and n, p, q and r are each an integer of 0.1 or 2]
priorityDate 2003-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507953

Total number of triples: 33.